Stock OTLK OUTLOOK THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Outlook Therapeutics, Inc.

Equities

OTLK

US69012T3059

Real-time Estimate Cboe BZX
Other stock markets
 11:37:59 2024-06-05 am EDT 		5-day change 1st Jan Change
7.43 USD +3.34% Intraday chart for Outlook Therapeutics, Inc. +3.51% -6.35%
May. 28 Outlook Therapeutics Granted EU Marketing Authorization for Lytenava to Treat Wet AMD MT
May. 28 Outlook Therapeutics, Inc. Receives European Commission Marketing Authorization for LYTENAVA? (bvacizumab grapa) for the Treatment of Wet AMD CI

MarketScreener Strategies

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OTLK Stock
  4. News Outlook Therapeutics, Inc.
  5. MarketScreener Strategies